The role of Transcranial Magnetic Stimulation in mental health care, featuring Eliza Brink, DNP, PMHNP-BC
Learn how Transcranial Magnetic Stimulation (TMS), a non-invasive neuromodulation technique, is used in the treatment of psychiatric disorders. We’ll detail the fundamental principles of TMS, including its mechanism of action and how it modulates functional connectivity within targeted neural circuits.
We’ll review FDA-approved indications for TMS, including major depressive disorder and obsessive-compulsive disorder, and examine emerging evidence supporting off-label uses such as post-traumatic stress disorder (PTSD).
We’ll also examine practical considerations for clinical implementation, including patient selection and integration with other treatment modalities.
Session objectives
By the end of this session, participants will be able to:
- Describe the fundamental principles of Transcranial Magnetic Stimulation (TMS), including its mechanism of action and neurobiological targets/circuits.
- Identify FDA-approved indications for TMS and discuss off-label uses supported by emerging research.
Eliza Brink, DNP, PMHNP-BC
Dr. Brink is an Associate Teaching Professor at the University of Washington School of Nursing. She is the founder of Spruce Psychiatric Associates, a practice that supports over 20 psychiatric nurse practitioners across Washington State through education, collaboration, and practice management.
Dr. Brink also co-founded an interventional clinic, Clear Path Psychiatry, to expand access to treatments including transcranial magnetic stimulation (TMS) and intranasal esketamine (Spravato). She currently serves on the Board of Directors for the International Clinical TMS Society.